Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ly Tu

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Chest|May 1, 2026
Impact of pulmonary arterial hypertension therapies on gas exchange in portopulmonary hypertensionThomas Lacoste-Palasset, Audrey Baron, Nathan Ebstein, et al.
ERJ Open Research|December 17, 2025
Long-term outcomes of Qing-Dai-induced pulmonary arterial hypertensionSarasa Isobe, Ly Tu, Yoshihiro Dohi, et al.
American Journal of Respiratory and Critical Care Medicine|August 4, 2012
Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertensionFrances S de Man, Ly Tu, M Louis Handoko, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 15, 2017
Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic SclerosisJérôme Avouac, Christophe Guignabert, Anna Maria Hoffmann-Vold, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2025
Bone morphogenetic protein-9 controls pulmonary vascular growth and remodelingNihel Berrebeh, Yvon Mbouamboua, Raphaël Thuillet, et al.
The European Respiratory Journal|December 22, 2019
Connexin-43 is a promising target for pulmonary hypertension due to hypoxaemic lung diseaseClaire Bouvard, Nafiisha Genet, Carole Phan, et al.
Journal of the American Heart Association|March 29, 2022
Platelet-Derived Growth Factor Receptor Type α Activation Drives Pulmonary Vascular Remodeling Via Progenitor Cell Proliferation and Induces Pulmonary HypertensionJulien Solinc, Jessica Raimbault-Machado, France Dierick, et al.
American Journal of Respiratory and Critical Care Medicine|April 16, 2024
Disrupted BMP-9 Signaling Impairs Pulmonary Vascular Integrity in Hepatopulmonary SyndromeFabien Robert, Marie-Caroline Certain, Audrey Baron, et al.
Frontiers in Physiology|June 19, 2018
Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary HypertensionTinne C J Mertens, Ankit Hanmandlu, Ly Tu, et al.
The European Respiratory Journal|July 6, 2019
Prevention of progression of pulmonary hypertension by the Nur77 agonist 6-mercaptopurine: role of BMP signallingKondababu Kurakula, Xiao-Qing Sun, Chris Happé, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Chest|May 1, 2026
Impact of pulmonary arterial hypertension therapies on gas exchange in portopulmonary hypertensionThomas Lacoste-Palasset, Audrey Baron, Nathan Ebstein, et al.
ERJ Open Research|December 17, 2025
Long-term outcomes of Qing-Dai-induced pulmonary arterial hypertensionSarasa Isobe, Ly Tu, Yoshihiro Dohi, et al.
American Journal of Respiratory and Critical Care Medicine|August 4, 2012
Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertensionFrances S de Man, Ly Tu, M Louis Handoko, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 15, 2017
Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic SclerosisJérôme Avouac, Christophe Guignabert, Anna Maria Hoffmann-Vold, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2025
Bone morphogenetic protein-9 controls pulmonary vascular growth and remodelingNihel Berrebeh, Yvon Mbouamboua, Raphaël Thuillet, et al.
The European Respiratory Journal|December 22, 2019
Connexin-43 is a promising target for pulmonary hypertension due to hypoxaemic lung diseaseClaire Bouvard, Nafiisha Genet, Carole Phan, et al.
Journal of the American Heart Association|March 29, 2022
Platelet-Derived Growth Factor Receptor Type α Activation Drives Pulmonary Vascular Remodeling Via Progenitor Cell Proliferation and Induces Pulmonary HypertensionJulien Solinc, Jessica Raimbault-Machado, France Dierick, et al.
American Journal of Respiratory and Critical Care Medicine|April 16, 2024
Disrupted BMP-9 Signaling Impairs Pulmonary Vascular Integrity in Hepatopulmonary SyndromeFabien Robert, Marie-Caroline Certain, Audrey Baron, et al.
Frontiers in Physiology|June 19, 2018
Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary HypertensionTinne C J Mertens, Ankit Hanmandlu, Ly Tu, et al.
The European Respiratory Journal|July 6, 2019
Prevention of progression of pulmonary hypertension by the Nur77 agonist 6-mercaptopurine: role of BMP signallingKondababu Kurakula, Xiao-Qing Sun, Chris Happé, et al.
Pageof 9